Health IT

GE Healthcare sells analytics company Caradigm to Inspirata

Caradigm is the second company that Inspirata has acquired from GE Healthcare this year. The first was Omnyx, a digital pathology organization.

Give and take concept on black background

Inspirata, a cancer diagnostics company headquartered in Tampa, Florida, has acquired analytics firm Caradigm from GE Healthcare.

Financial details of the deal were not disclosed.

Redmond, Washington-based Caradigm offers a variety of population health solutions, including services based on data control, analytics and care coordination and patient engagement. Its Caradigm Intelligence Platform brings together information from disparate systems, and healthcare organizations can leverage the data to improve care. The company’s clients span from ACOs to community hospitals to academic medical centers.

“We are confident that Inspirata will be able to provide the intense focus and vision needed for growth through key investments in technology, infrastructure and people to energize the Caradigm software portfolio to better enable us to serve customers’ evolving needs,” Caradigm president and CEO Neal Singh said in a news release.

Singh took the helm of the company in 2016 when he was promoted from the CTO role.

For almost four years, the Washington organization was a joint venture between GE Healthcare and Microsoft. But in April 2016, General Electric bought out Microsoft’s stake, turning Caradigm into an operating affiliate of GE Healthcare.

Now, GE Healthcare has sold it to Inspirata, which plans to use Caradigm’s assets to expedite the development of its Cancer Information Data Trust, CEO Satish Sanan said in a news release. The CIDT is an oncology big data platform that can provide insight to clinicians, researchers and cancer centers. Additionally, Sanan said Inspirata will leverage Caradigm’s population health services to help with its long-term innovation goals.

Caradigm is the second company that Inspirata has acquired from GE Healthcare this year.

At the end of January, GE Healthcare sold Omnyx, a digital pathology organization, to Inspirata. Again, the financial details weren’t disclosed.

The Pittsburgh, Pennsylvania company’s core product, Dynamyx, focuses on the pathology workflow and provides tools for collaboration among members of the cancer care team.

“[The acquisition] brings us the last mile to reach our goal of having an end-to-end integrated pathology solution with a scanner-agnostic whole slide image viewer and image management system,” Sanan said at the time, according to a news release.

GE Healthcare has been making other deals in 2018 as well. This spring, it announced plans to sell part of its health IT unit to private equity firm Veritas Capital for $1.05 billion. The purchase will include GE’s enterprise financial management, ambulatory care management and workforce management assets. The companies anticipate the deal will close in the third quarter of this year.

Photo: crazydiva, Getty Images

Shares1
Shares1